RG
TEVA icon

Retirement Group’s Teva Pharmaceuticals TEVA Stock Holding History

Retirement Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.41K Hold
100
– – ﹤0.01% 686
2023
Q4 		$1.04K Hold
100
– – ﹤0.01% 700
2023
Q3 		$1.02K Hold
100
– – ﹤0.01% 639
2023
Q2 		$753 Hold
100
– – ﹤0.01% 690
2023
Q1 		$1K Buy
+100
New +$989 ﹤0.01% 662
2022
Q1 		– Sell
-31
Closed – – 827
2021
Q4 		$0 Hold
31
– – ﹤0.01% 752
2021
Q3 		$0 Buy
+31
New +$290 ﹤0.01% 705
2020
Q4 		– Sell
-1,000
Closed -$9K – 732
2020
Q3 		$9K Hold
1,000
– – 0.01% 431
2020
Q2 		$12K Buy
+1,000
New +$11.3K 0.01% 373
2019
Q4 		$10K Buy
+1,000
New +$8.93K 0.01% 387

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Retirement Group's TEVA Position: Q1 2024 in Review

Retirement Group held its Teva Pharmaceuticals (TEVA) position steady in Q1 2024 at 100 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #686.

Retirement Group first reported a position in TEVA in Q4 2019 and has held it in 10 quarters since. The position peaked at $12K in Q2 2020. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • Retirement Group held 100 shares of Teva Pharmaceuticals worth $1.41K as of Q1 2024.
  • Retirement Group left its Teva Pharmaceuticals share count unchanged in Q1 2024.
  • Teva Pharmaceuticals made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #686 holding.
  • Retirement Group first reported a position in Teva Pharmaceuticals in Q4 2019 and has held it in 10 quarters since.
  • Retirement Group's Teva Pharmaceuticals position peaked at $12K in Q2 2020.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.